Latest Insider Transactions at Clover Health Investments, Corp. (CLOV)
This section provides a real-time view of insider transactions for Clover Health Investments, Corp. (CLOV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CLOVER HEALTH INVESTMENTS, CORP. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CLOVER HEALTH INVESTMENTS, CORP. 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 18
2024
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
32,416
-1.71%
|
$32,416
$1.69 P/Share
|
|
Jul 03
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
5,388
-0.21%
|
$5,388
$1.25 P/Share
|
|
Jul 01
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308,341
-2.94%
|
$308,341
$1.2 P/Share
|
|
Jun 30
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
52,967
-1.98%
|
$52,967
$1.23 P/Share
|
|
Jun 30
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
217,522
+7.52%
|
-
|
|
Jun 30
2024
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
137,108
-6.11%
|
$137,108
$1.23 P/Share
|
|
Jun 30
2024
|
Aric R Sharp CEO of Value Based Care |
BUY
Grant, award, or other acquisition
|
Direct |
456,265
+16.89%
|
-
|
|
Jun 17
2024
|
Vivek Garipalli Director |
BUY
Open market or private purchase
|
Direct |
877,567
+50.0%
|
$877,567
$1.14 P/Share
|
|
Jun 15
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,499
-0.46%
|
$4,499
$1.09 P/Share
|
|
Jun 15
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
5,378
-0.22%
|
$5,378
$1.09 P/Share
|
|
Jun 14
2024
|
Conrad Wai Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
69,148
-2.37%
|
$69,148
$1.09 P/Share
|
|
Jun 14
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
7,776
-0.32%
|
$7,776
$1.09 P/Share
|
|
May 17
2024
|
Anna U Loengard Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.93 P/Share
|
|
May 16
2024
|
Anna U Loengard Director |
BUY
Open market or private purchase
|
Indirect |
17,085
+29.47%
|
$0
$0.95 P/Share
|
|
May 14
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,241
-0.53%
|
$5,241
$1.02 P/Share
|
|
May 09
2024
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
6,798
-0.38%
|
$0
$0.86 P/Share
|
|
May 08
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,367
-0.81%
|
$0
$0.87 P/Share
|
|
Apr 18
2024
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
32,416
-1.68%
|
$0
$0.63 P/Share
|
|
Apr 03
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
5,387
-0.22%
|
$0
$0.76 P/Share
|
|
Apr 01
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308,341
-2.83%
|
$0
$0.77 P/Share
|
|
Mar 15
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,168
-0.52%
|
$0
$0.8 P/Share
|
|
Mar 15
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
5,378
-0.22%
|
$0
$0.8 P/Share
|
|
Mar 14
2024
|
Conrad Wai Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
74,396
-2.48%
|
$0
$0.73 P/Share
|
|
Mar 14
2024
|
Anna U Loengard Director |
BUY
Open market or private purchase
|
Indirect |
13,625
+47.39%
|
$0
$0.73 P/Share
|
|
Mar 14
2024
|
Anna U Loengard Director |
BUY
Open market or private purchase
|
Direct |
137,000
+20.27%
|
$0
$0.73 P/Share
|
|
Mar 14
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
7,777
-0.31%
|
$0
$0.73 P/Share
|
|
Feb 14
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,020
-0.6%
|
$0
$0.95 P/Share
|
|
Feb 09
2024
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
8,266
-0.46%
|
$8,266
$1.02 P/Share
|
|
Feb 08
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,367
-0.78%
|
$85,367
$1.0 P/Share
|
|
Jan 25
2024
|
Scott J. Leffler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83,538
-1.69%
|
$0
$0.98 P/Share
|
|
Jan 18
2024
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
38,030
-1.93%
|
$0
$0.98 P/Share
|
|
Jan 07
2024
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,561,065
-100.0%
|
$0
$0.95 P/Share
|
|
Jan 07
2024
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,561,065
+50.0%
|
-
|
|
Jan 07
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
16,369
-0.65%
|
$0
$0.95 P/Share
|
|
Jan 07
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,862
-0.39%
|
$0
$0.95 P/Share
|
|
Jan 03
2024
|
Chelsea Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+27.56%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+33.91%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+33.34%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
William G Robinson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+31.06%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Lee Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+27.72%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+30.69%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
26,240
-1.04%
|
$0
$0.92 P/Share
|
|
Jan 01
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
1,559
-0.06%
|
$0
$0.95 P/Share
|
|
Jan 01
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084,906
-8.99%
|
$0
$0.95 P/Share
|
|
Dec 15
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,691
-0.34%
|
$0
$0.99 P/Share
|
|
Dec 15
2023
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,361
-0.43%
|
$0
$0.99 P/Share
|
|
Dec 14
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
12,567
-0.49%
|
$12,567
$1.0 P/Share
|
|
Dec 14
2023
|
Conrad Wai Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
96,086
-3.11%
|
$96,086
$1.0 P/Share
|
|
Nov 14
2023
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,079
-0.5%
|
$5,079
$1.01 P/Share
|
|
Nov 09
2023
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
10,515
-0.58%
|
$0
$0.88 P/Share
|